Performance-Linked Stock Acquisition Rights and Restricted Stock Compensation
First written in FY2020. 12 of 17 entries say "Advanced", first in FY2021-Q2. Latest entry: 2026-11-11.
106 other companies' latest entry also says "Advanced".
- FY2026-H1RaisedAnnual report
「These stock acquisition rights are being issued to further enhance the commitment of directors and employees, including the company's founding president, to business performance and corporate value, provide incentives for share price appreciation and promote greater value sharing with shareholders as the company seeks to expand its business performance and increase corporate value over the medium to long term. The holders of the stock acquisition rights may exercise, beginning on the first day of the month following the filing date of the annual securities report confirming that the relevant condition has been met, up to the specified exerciseable percentage of their allocated stock acquisition rights if the company's operating profit exceeds the target level, referred to below as target operating profit, in any of the determination fiscal years specified in (a) through (c): (a) Determination fiscal years: fiscal years ending March 2027 through March 2031; target operating profit: ¥7.75 billion; exerciseable percentage: 33%; (b) Determination fiscal years: fiscal years ending March 2027 through March 2033; target operating profit: ¥8.75 billion; exerciseable percentage: 66%; (c) Determination fiscal years: fiscal years ending March 2027 through March 2036; target operating profit: ¥10 billion; exerciseable percentage: 100%.」
The company expanded from the previous stock acquisition rights subject to an operating profit condition of ¥4 billion to a new performance-linked scheme with phased conditions of ¥7.75 billion, ¥8.75 billion and ¥10 billion in operating profit, while extending the determination period through the fiscal year ending March 2036. - FY2025-H1AdvancedAnnual report
「16 July 2024 13,940 16,211,535 32,271 4,218,856 32,271 4,218,856 (Note) 2. The increase resulted from the issuance of new shares as restricted stock compensation.」
On 16 July 2024, the company issued 13,940 shares as restricted stock compensation, increasing capital and capital surplus by ¥32.271 million each. - FY2024-Q2ReframedAnnual report
「The holders of the stock acquisition rights may exercise these rights only if the company's operating profit exceeds ¥4 billion in any of the 5 fiscal years from the fiscal year ending March 2025 through the fiscal year ending March 2029, referred to below as the determination fiscal years.」
For the issue of stock acquisition rights in November 2023, the company disclosed a new performance-linked scheme under which operating profit exceeding ¥4 billion in any fiscal year from the fiscal year ending March 2025 through the fiscal year ending March 2029 is an exercise condition. - FY2024-Q1AdvancedAnnual report
「1 April 2023–30 June 2023 2,700 16,162,715 2,452 4,150,107 2,452 4,150,107 (Note) 1. The increase resulted from the exercise of stock acquisition rights (stock options). 2. Between 1 July 2023 and 31 July 2023, the exercise of stock acquisition rights (stock options) increased the total number of issued shares by 3,000 shares and increased capital and capital surplus by ¥2.533 million each. 3. The issuance of new shares as restricted stock compensation, with 12 July 2023 as the payment date, increased the total number of issued shares by 14,180 shares and increased capital and capital surplus by ¥28.608 million each.」
The company issued 2,700 shares through the exercise of stock acquisition rights in the first quarter and, before the filing date, completed the exercise of rights for 3,000 shares and issued 14,180 shares as restricted stock compensation. - FY2023-Q3AdvancedAnnual report
「1 October 2022–31 December 2022 1,398 16,155,995 1,218 4,143,996 1,218 4,143,996 (Note) The increase resulted from the exercise of stock acquisition rights (stock options).」
The company issued 1,398 shares through the exercise of stock acquisition rights in the third quarter, increasing capital and capital surplus by ¥1.218 million each. - FY2023-Q2AdvancedAnnual report
「The increase in issued shares from the end of the second quarter accounting period through the filing date resulted from the issuance of new shares through the exercise of stock acquisition rights (stock options).」
The company continued issuing shares through the exercise of stock acquisition rights between the end of the second quarter and the filing date, bringing issued shares to 16,155,797 as of the filing date. - FY2023-Q1AdvancedAnnual report
「1 April 2022–28 June 2022 198,600 16,135,837 33,738 4,122,339 33,738 4,122,339 29 June 2022 18,760 16,154,597 20,439 4,142,778 20,439 4,142,778」
The company issued 198,600 shares through the exercise of stock acquisition rights in the first quarter and issued 18,760 shares as restricted stock compensation on 29 June. - FY2022-Q3AdvancedAnnual report
「1 October 2021–31 December 2021 3,090 15,550,237 618 3,637,117 618 3,637,117 (Note) The increase resulted from the exercise of stock acquisition rights (stock options).」
The company issued 3,090 shares through the exercise of stock acquisition rights in the third quarter, increasing capital and capital surplus by ¥618,000 each. - FY2022-Q2AdvancedAnnual report
「1 July 2021–30 September 2021 8,982 15,547,147 1,751 3,636,499 1,751 3,636,499 (Note) 2. The increase resulted from the exercise of stock acquisition rights.」
The company issued 8,982 shares through the exercise of stock acquisition rights in the second quarter, increasing capital and capital surplus by ¥1.751 million each. - FY2022-Q1AdvancedAnnual report
「1 April 2021–30 June 2021 184,464 15,532,615 31,535 3,616,239 31,535 3,616,239 (Note) 1. The increase resulted from the exercise of stock acquisition rights. 2. On 1 July 2021, the issuance of new shares as restricted stock compensation increased the total number of issued shares by 5,550 shares and increased capital and capital surplus by ¥18.509 million each.」
The company issued 184,464 shares through the exercise of stock acquisition rights in the first quarter and issued a further 5,550 shares as restricted stock compensation after the quarter-end. - FY2021AdvancedAnnual report
「The beneficiaries may exercise the Series 8 Stock Acquisition Rights only if the company's net sales exceed ¥7 billion in any fiscal year from the fiscal year ending March 2021 through the fiscal year ending March 2023 and its operating profit exceeds ¥900 million in any fiscal year during the same period.」
In addition to the previous Series 7 Stock Acquisition Rights, the company has established performance conditions of ¥7 billion in net sales and ¥900 million in operating profit for the Series 8 Stock Acquisition Rights. - FY2021-Q2AdvancedAnnual report
「The increase resulted from the issuance of new shares as restricted stock compensation.」
On 10 July 2020, the company issued 7,400 shares as restricted stock compensation and allocated them to 5 directors and executive officers in total. - FY2020First statedAnnual report
「The Series 7 Stock Acquisition Rights may be exercised only if the company's net sales exceed ¥7 billion in any fiscal year from the fiscal year ending March 2021 through the fiscal year ending March 2023 and its operating profit exceeds ¥900 million in any fiscal year during the same period.」
The company issued stock acquisition rights subject to net sales of ¥7 billion and operating profit of ¥900 million, and separately introduced restricted stock compensation capped at ¥30 million per year and 15,000 shares per year.